These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry. Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349 [TBL] [Abstract][Full Text] [Related]
27. Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation. Chen HS; Ho MC; Hu RH; Wu JF; Chen HL; Ni YH; Hsu HY; Jeng YM; Chang MH J Formos Med Assoc; 2019 Sep; 118(9):1362-1368. PubMed ID: 30612881 [TBL] [Abstract][Full Text] [Related]
28. Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient. Hu J; Yu YW; Han DS; Li XJ; Zhang YQ; Cai HL; Xiao YH; Zheng X Front Immunol; 2023; 14():1244534. PubMed ID: 37781359 [TBL] [Abstract][Full Text] [Related]
29. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients. Liu M; Husain S; Famure O; Li Y; Kim SJ Prog Transplant; 2019 Jun; 29(2):185-193. PubMed ID: 30845885 [TBL] [Abstract][Full Text] [Related]
30. Comparison of Clinical Features and Outcome of Pediatric Posttransplant Lymphoproliferative Disorder in Recipients of Small Bowel Allograft Versus Isolated Liver Transplantation. Chiou FK; Beath SV; Morland B; Hartley J; van Mourik I; Abdel-Hady M; Kelly DA; Sharif K; Gupte GL Transplantation; 2020 Jul; 104(7):1429-1436. PubMed ID: 31651718 [TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case. Shitrit D; Shitrit AB; Dickman R; Sahar G; Saute M; Kramer MR Dis Colon Rectum; 2005 Nov; 48(11):2144-7. PubMed ID: 16086224 [TBL] [Abstract][Full Text] [Related]
32. Recurrent Intestinal Perforation After Cessation of Immunosuppression in Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipient. Valamparampil JJ; Palaniappan K; Vij M; Shanmugam N; Ramachandran P; Ramachandran B; Rela M J Gastrointest Cancer; 2021 Sep; 52(3):1165-1168. PubMed ID: 33751328 [TBL] [Abstract][Full Text] [Related]
33. A Scheduled Program of Molecular Screening for Epstein-Barr Virus Decreases the Incidence of Post-transplantation Lymphoproliferative Disease in Pediatric Liver Transplantation. Soriano-López DP; Alcántar-Fierros JM; Hernández-Plata JA; González-Jorge AL; Velázquez-Ramos S; Flores-Hernández MA; Fuentes V; Castañeda P; Nieto J; Sánchez JL; López B; Valencia-Mayoral P; Varela-Fascinetto G Transplant Proc; 2016 Mar; 48(2):654-7. PubMed ID: 27110023 [TBL] [Abstract][Full Text] [Related]
34. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S; Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985 [TBL] [Abstract][Full Text] [Related]
35. A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient. Tang WR; Hsu CW; Lee CC; Huang WL; Lin CY; Hsu YT; Chang C; Tsai MT; Hu YN; Hsu CH; Chen PL; Chow NH; Roan JN Transplant Proc; 2022; 54(6):1575-1578. PubMed ID: 34702598 [TBL] [Abstract][Full Text] [Related]